source
- Roche's Genentech to invest $750 million to double Oregon manufacturing siteRoche's Genentech announced a $750 million investment to expand its existing production facility in Oregon, with the goal of doubling its capacity. The expanded site is expected to boost manufactu…
- Takeda wins FDA nod for orexin drug oveporexton, first treatment for narcolepsy type 1 and potential broader usesTakeda received FDA approval for oveporexton (brand Orzeyful), an orexin receptor agonist, marking the first approved therapy that targets the orexin system for narcolepsy type 1. The drug mimics…